Psychosocial dwarfism: psychopathological aspects and putative neuroendocrine markers.
There exists an extensive terminology for defining the situation of children who, in varying circumstances, suffer from affective deprivation (AD), within an unsatisfactory family situation or in institutions. Nevertheless, the neuroendocrine mechanisms (if they exist) determining it have yet to be identified. Our objective was to determine if specific neuroendocrine markers, all of them previously implicated in affective disorders, could be modified, and in which sense, in affective deprivation syndrome of the child. For this purpose, we studied three separate groups of children: (1) control group (CG); (2) children suffering from AD; and (3) children with non-organic failure to thrive (NOFT). In every case, we studied the serum levels of melatonin, serotonin, β-endorphins and adrenocorticotropic hormone (ACTH); and kynurenine pathway tryptophan metabolites (both during the day and at night). Significantly, there was a conspicuous reduction in the levels of each of the neuroendocrine markers (melatonin, serotonin, β-endorphins and ACTH) in the group suffering from affective deficiency, a diminution which was even more noticeable in the group of patients presenting delayed growth. Furthermore, as also occurs in other affective disorders, there were corresponding modifications in the metabolisation of tryptophan. We report the existence of neuroendocrine mechanisms that are associated with the above-mentioned clinical manifestations in these patients, mechanisms that may underlie the close connection existing between AD syndrome and the cause of NOFT. These data suggest that the AD syndrome and NOFT comprise a single process, but one with a different evolutionary continuum of psychosocial dwarfism.
Unidad de Gestion Clinica de Pediatria, Hospital Universitario San Cecilio, Universidad de Granada, Spain.
Antonio
A
Muñoz-Hoyos
Antonio
A
Molina-Carballo
Maríadelcarmen
M
Augustin-Morales
Francisco
F
Contreras-Chova
Ana
A
Naranjo-Gómez
Fuensanta
F
Justicia-Martínez
José
J
Uberos
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000704:Analysis of Variance; D016009:Chi-Square Distribution; D002648:Child; D002653:Child Behavior Disorders / Q000378:metabolism / Q000473:pathology / Q000523:psychology; D002675:Child, Preschool; D002940:Circadian Rhythm / Q000502:physiology; D002658:Developmental Disabilities / Q000378:metabolism / Q000473:pathology / Q000523:psychology; D004392:Dwarfism; D005183:Failure to Thrive / Q000378:metabolism / Q000523:psychology; D005260:Female; D006801:Humans; D007737:Kynurenine / Q000652:urine; D008297:Male; D008550:Melatonin / Q000097:blood; D009490:Neurosecretory Systems / Q000378:metabolism*; D011599:Psychopathology; D012701:Serotonin / Q000097:blood; D001615:beta-Endorphin / Q000097:blood
D012701:Serotonin; D007737:Kynurenine; D001615:beta-Endorphin; D000324:Adrenocorticotropic Hormone; D008550:Melatonin